These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): efficacy in an animal model for schizophrenia. Govek SP; Bonnefous C; Hutchinson JH; Kamenecka T; McQuiston J; Pracitto R; Zhao LX; Gardner MF; James JK; Daggett LP; Rowe BA; Schaffhauser H; Bristow LJ; Campbell UC; Rodriguez DE; Vernier JM Bioorg Med Chem Lett; 2005 Sep; 15(18):4068-72. PubMed ID: 16005222 [TBL] [Abstract][Full Text] [Related]
6. Biphenyl-indanones: allosteric potentiators of the metabotropic glutamate subtype 2 receptor. Bonnefous C; Vernier JM; Hutchinson JH; Gardner MF; Cramer M; James JK; Rowe BA; Daggett LP; Schaffhauser H; Kamenecka TM Bioorg Med Chem Lett; 2005 Oct; 15(19):4354-8. PubMed ID: 16046122 [TBL] [Abstract][Full Text] [Related]
7. Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamine. Johnson MP; Baez M; Jagdmann GE; Britton TC; Large TH; Callagaro DO; Tizzano JP; Monn JA; Schoepp DD J Med Chem; 2003 Jul; 46(15):3189-92. PubMed ID: 12852748 [TBL] [Abstract][Full Text] [Related]
8. SAR study of a subtype selective allosteric potentiator of metabotropic glutamate 2 receptor, N-(4-phenoxyphenyl)-N-(3-pyridinylmethyl)ethanesulfonamide. Barda DA; Wang ZQ; Britton TC; Henry SS; Jagdmann GE; Coleman DS; Johnson MP; Andis SL; Schoepp DD Bioorg Med Chem Lett; 2004 Jun; 14(12):3099-102. PubMed ID: 15149652 [TBL] [Abstract][Full Text] [Related]
9. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists. Johnson MP; Nisenbaum ES; Large TH; Emkey R; Baez M; Kingston AE Biochem Soc Trans; 2004 Nov; 32(Pt 5):881-7. PubMed ID: 15494040 [TBL] [Abstract][Full Text] [Related]
10. Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs. Wágner G; Wéber C; Nyéki O; Nógrádi K; Bielik A; Molnár L; Bobok A; Horváth A; Kiss B; Kolok S; Nagy J; Kurkó D; Gál K; Greiner I; Szombathelyi Z; Keseru GM; Domány G Bioorg Med Chem Lett; 2010 Jun; 20(12):3737-41. PubMed ID: 20483612 [TBL] [Abstract][Full Text] [Related]
11. 3-[3-Fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonist. Poon SF; Eastman BW; Chapman DF; Chung J; Cramer M; Holtz G; Cosford ND; Smith ND Bioorg Med Chem Lett; 2004 Nov; 14(22):5477-80. PubMed ID: 15482907 [TBL] [Abstract][Full Text] [Related]
12. 9H-Xanthene-9-carboxylic acid [1,2,4]oxadiazol-3-yl- and (2H-tetrazol-5-yl)-amides as potent, orally available mGlu1 receptor enhancers. Vieira E; Huwyler J; Jolidon S; Knoflach F; Mutel V; Wichmann J Bioorg Med Chem Lett; 2005 Oct; 15(20):4628-31. PubMed ID: 16099654 [TBL] [Abstract][Full Text] [Related]
13. Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo. Lindsley CW; Wisnoski DD; Leister WH; O'brien JA; Lemaire W; Williams DL; Burno M; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Duggan ME; Hartman GD; Conn PJ; Huff JR J Med Chem; 2004 Nov; 47(24):5825-8. PubMed ID: 15537338 [TBL] [Abstract][Full Text] [Related]